These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 31019462)

  • 1. Macrophage Death as a Pharmacological Target in Atherosclerosis.
    Martinet W; Coornaert I; Puylaert P; De Meyer GRY
    Front Pharmacol; 2019; 10():306. PubMed ID: 31019462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated Necrosis in Atherosclerosis.
    Puylaert P; Zurek M; Rayner KJ; De Meyer GRY; Martinet W
    Arterioscler Thromb Vasc Biol; 2022 Nov; 42(11):1283-1306. PubMed ID: 36134566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis.
    Lin L; Zhang MX; Zhang L; Zhang D; Li C; Li YL
    Front Cell Dev Biol; 2021; 9():809955. PubMed ID: 35096837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets.
    De Meyer GRY; Zurek M; Puylaert P; Martinet W
    Nat Rev Cardiol; 2024 May; 21(5):312-325. PubMed ID: 38163815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage death in atherosclerosis: potential role in calcification.
    Neels JG; Gollentz C; Chinetti G
    Front Immunol; 2023; 14():1215612. PubMed ID: 37469518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The walking dead: macrophage inflammation and death in atherosclerosis.
    Kavurma MM; Rayner KJ; Karunakaran D
    Curr Opin Lipidol; 2017 Apr; 28(2):91-98. PubMed ID: 28134664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Apoptosis and Necrotic Core Development in Atherosclerosis: A Rapidly Advancing Field with Clinical Relevance to Imaging and Therapy.
    Gonzalez L; Trigatti BL
    Can J Cardiol; 2017 Mar; 33(3):303-312. PubMed ID: 28232016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis.
    Karunakaran D; Geoffrion M; Wei L; Gan W; Richards L; Shangari P; DeKemp EM; Beanlands RA; Perisic L; Maegdefessel L; Hedin U; Sad S; Guo L; Kolodgie FD; Virmani R; Ruddy T; Rayner KJ
    Sci Adv; 2016 Jul; 2(7):e1600224. PubMed ID: 27532042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis.
    Rasheed A; Robichaud S; Nguyen MA; Geoffrion M; Wyatt H; Cottee ML; Dennison T; Pietrangelo A; Lee R; Lagace TA; Ouimet M; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1155-1167. PubMed ID: 32212851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Function, Regulation and Mechanism of Programmed Cell Death of Macrophages in Atherosclerosis.
    Liu C; Jiang Z; Pan Z; Yang L
    Front Cell Dev Biol; 2021; 9():809516. PubMed ID: 35087837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
    Thorp E; Tabas I
    J Leukoc Biol; 2009 Nov; 86(5):1089-95. PubMed ID: 19414539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos.
    Robinson N; Ganesan R; Hegedűs C; Kovács K; Kufer TA; Virág L
    Redox Biol; 2019 Sep; 26():101239. PubMed ID: 31212216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress.
    Tabas I
    Antioxid Redox Signal; 2009 Sep; 11(9):2333-9. PubMed ID: 19243235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and consequences of macrophage apoptosis in atherosclerosis.
    Seimon T; Tabas I
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S382-7. PubMed ID: 18953058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages but not smooth muscle cells undergo benzyloxycarbonyl-Val-Ala-DL-Asp(O-Methyl)-fluoromethylketone-induced nonapoptotic cell death depending on receptor-interacting protein 1 expression: implications for the stabilization of macrophage-rich atherosclerotic plaques.
    Martinet W; De Meyer GR; Timmermans JP; Herman AG; Kockx MM
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1356-64. PubMed ID: 16537794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of efferocytosis in atherosclerosis.
    Shu LX; Cao LL; Guo X; Wang ZB; Wang SZ
    J Mol Med (Berl); 2024 Jul; 102(7):831-840. PubMed ID: 38727748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis.
    Coornaert I; Hofmans S; Devisscher L; Augustyns K; Van Der Veken P; De Meyer GRY; Martinet W
    Expert Opin Drug Discov; 2018 Jun; 13(6):477-488. PubMed ID: 29598451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture.
    Boyle JJ
    Curr Vasc Pharmacol; 2005 Jan; 3(1):63-8. PubMed ID: 15638783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
    Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
    Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular mechanisms of macrophage survival in atherosclerosis.
    Martinet W; Schrijvers DM; De Meyer GR
    Basic Res Cardiol; 2012 Nov; 107(6):297. PubMed ID: 22968334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.